Annual Retained Earnings
-$451.06 M
-$57.56 M-14.63%
December 31, 2022
Summary
- As of February 10, 2025, NLTX annual retained earnings is -$451.06 million, with the most recent change of -$57.56 million (-14.63%) on December 31, 2022.
- During the last 3 years, NLTX annual retained earnings has fallen by -$151.53 million (-50.59%).
Performance
NLTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Retained Earnings
-$471.87 M
-$4.53 M-0.97%
September 30, 2023
Summary
- As of February 10, 2025, NLTX quarterly retained earnings is -$471.87 million, with the most recent change of -$4.53 million (-0.97%) on September 30, 2023.
- Over the past year, NLTX quarterly retained earnings has dropped by -$34.26 million (-7.83%).
Performance
NLTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
NLTX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.6% | -7.8% |
| 3 y3 years | -50.6% | -47.4% |
| 5 y5 years | -127.2% | -109.5% |
NLTX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +14.6% | at low | +19.9% | at low |
| 5 y | 5-year | +50.6% | at low | +57.5% | at low |
| alltime | all time | +773.5% | at low | +618.3% | at low |
Neoleukin Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$471.87 M(+1.0%) |
| Jun 2023 | - | -$467.34 M(+0.4%) |
| Mar 2023 | - | -$465.26 M(+3.1%) |
| Dec 2022 | -$451.06 M(+14.6%) | -$451.06 M(+3.1%) |
| Sep 2022 | - | -$437.61 M(+3.1%) |
| Jun 2022 | - | -$424.54 M(+3.8%) |
| Mar 2022 | - | -$408.85 M(+3.9%) |
| Dec 2021 | -$393.50 M(+18.2%) | -$393.50 M(+4.0%) |
| Sep 2021 | - | -$378.33 M(+4.3%) |
| Jun 2021 | - | -$362.88 M(+4.4%) |
| Mar 2021 | - | -$347.76 M(+4.5%) |
| Dec 2020 | -$332.81 M(+11.1%) | -$332.81 M(+3.9%) |
| Sep 2020 | - | -$320.17 M(+0.7%) |
| Jun 2020 | - | -$317.92 M(+3.2%) |
| Mar 2020 | - | -$308.17 M(+2.9%) |
| Dec 2019 | -$299.53 M(+30.2%) | -$299.53 M(+2.8%) |
| Sep 2019 | - | -$291.43 M(+25.5%) |
| Jun 2019 | - | -$232.30 M(+0.0%) |
| Mar 2019 | - | -$232.29 M(+1.0%) |
| Dec 2018 | -$230.09 M | -$230.09 M(+2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | -$225.20 M(+7.1%) |
| Jun 2018 | - | -$210.21 M(-1.4%) |
| Mar 2018 | - | -$213.13 M(+7.4%) |
| Dec 2017 | -$198.50 M(+33.9%) | -$198.50 M(+8.9%) |
| Sep 2017 | - | -$182.23 M(+6.9%) |
| Jun 2017 | - | -$170.40 M(+8.8%) |
| Mar 2017 | - | -$156.63 M(+5.6%) |
| Dec 2016 | -$148.28 M(+33.3%) | -$148.28 M(+8.2%) |
| Sep 2016 | - | -$137.03 M(+6.3%) |
| Jun 2016 | - | -$128.89 M(+9.2%) |
| Mar 2016 | - | -$117.99 M(+6.0%) |
| Dec 2015 | -$111.28 M(+24.4%) | -$111.28 M(+5.4%) |
| Sep 2015 | - | -$105.61 M(+5.0%) |
| Jun 2015 | - | -$100.58 M(+5.0%) |
| Mar 2015 | - | -$95.83 M(+7.2%) |
| Dec 2014 | -$89.42 M(+36.1%) | -$89.42 M(+9.9%) |
| Sep 2014 | - | -$81.33 M(+8.4%) |
| Jun 2014 | - | -$75.04 M(+7.8%) |
| Mar 2014 | - | -$69.62 M(+6.0%) |
| Dec 2013 | -$65.69 M(+27.2%) | -$65.69 M |
| Dec 2012 | -$51.64 M | - |
FAQ
- What is Neoleukin Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics annual retained earnings year-on-year change?
- What is Neoleukin Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics quarterly retained earnings year-on-year change?
What is Neoleukin Therapeutics annual retained earnings?
The current annual retained earnings of NLTX is -$451.06 M
What is the all time high annual retained earnings for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high annual retained earnings is -$51.64 M
What is Neoleukin Therapeutics annual retained earnings year-on-year change?
Over the past year, NLTX annual retained earnings has changed by -$57.56 M (-14.63%)
What is Neoleukin Therapeutics quarterly retained earnings?
The current quarterly retained earnings of NLTX is -$471.87 M
What is the all time high quarterly retained earnings for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high quarterly retained earnings is -$65.69 M
What is Neoleukin Therapeutics quarterly retained earnings year-on-year change?
Over the past year, NLTX quarterly retained earnings has changed by -$34.26 M (-7.83%)